Aspirin in ET: will twice a day keep thrombosis away?

被引：2
作者：
Braunstein, Keep Evan M. [1 ]
Chaturvedi, Shruti [1 ]
机构：
[1] Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA
来源：
BLOOD | 2020年 / 136卷 / 02期
关键词：
ESSENTIAL THROMBOCYTHEMIA; BIOSYNTHESIS; RISK;
D O I：
10.1182/blood.2020005970
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
In this issue of Blood, Rocca et al show that aspirin insensitivity or incomplete platelet inhibition with standard once-per-day low-dose aspirin in patients with essential thrombocythemia (ET) is overcome by twice-per-day dosing of low-dose aspirin without an increase in adverse effects. This presents an attractive strategy for improving vascular outcomes in ET.(1)
引用
收藏
页码：151 / 153
页数：3
相关论文
共 10 条
  • [1] Observation versus antiplatelet therapy as primary prophylaxis for thrombosis in low-risk essential thrombocythemia
    Alvarez-Larran, Alberto
    Cervantes, Francisco
    Pereira, Arturo
    Arellano-Rodrigo, Eduardo
    Perez-Andreu, Virginia
    Hernandez-Boluda, Juan-Carlos
    Ayats, Ramon
    Salvador, Carlos
    Muntanola, Ana
    Bellosillo, Beatriz
    Vicente, Vicente
    Hernandez-Nieto, Luis
    Burgaleta, Carmen
    Xicoy, Blanca
    Besses, Carlos
    [J]. BLOOD, 2010, 116 (08) : 1205 - 1210
  • [2] Cyclooxygenase inhibitors and the antiplatelet effects of aspirin.
    Catella-Lawson, F
    Reilly, MP
    Kapoor, SC
    Cucchiara, AJ
    DeMarco, S
    Tournier, B
    Vyas, SN
    FitzGerald, GA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (25) : 1809 - 1817
  • [3] Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments
    De Stefano, Valerio
    Za, Tommaso
    Rossi, Elena
    Vannucchi, Alessandro M.
    Ruggeri, Marco
    Elli, Elena
    Mico, Caterina
    Tieghi, Alessia
    Cacciola, Rossella R.
    Santoro, Cristina
    Gerli, Giancarla
    Vianelli, Nicola
    Guglielmelli, Paola
    Pieri, Lisa
    Scognamiglio, Francesca
    Rodeghiero, Francesco
    Pogliani, Enrico M.
    Finazzi, Guido
    Gugliotta, Luigi
    Marchioli, Roberto
    Leone, Giuseppe
    Barbui, Tiziano
    [J]. HAEMATOLOGICA, 2008, 93 (03) : 372 - 380
  • [4] The contribution of cyclooxygenase-1 and-2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy
    Dragani, Alfredo
    Pascale, Silvia
    Recchiuti, Antonio
    Mattoscio, Domenico
    Lattanzio, Stefano
    Petrucci, Giovanna
    Mucci, Luciana
    Ferrante, Elisabetta
    Habib, Aida
    Ranelletti, Franco O.
    Ciabattoni, Giovanni
    Davi, Giovanni
    Patrono, Carlo
    Rocca, Bianca
    [J]. BLOOD, 2010, 115 (05) : 1054 - 1061
  • [5] Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events
    Eikelboom, JW
    Hirsh, J
    Weitz, JI
    Johnston, M
    Yi, Q
    Yusuf, S
    [J]. CIRCULATION, 2002, 105 (14) : 1650 - 1655
  • [6] Efficacy and safety of low-dose aspirin in polycythemia vera
    Landolfi, R
    Marchioli, R
    Kutti, J
    Gisslinger, H
    Tognoni, G
    Patrono, C
    Barbui, T
    Landolfi, R
    Marchioli, R
    Kutti, J
    Gisslinger, H
    Tognoni, G
    Patrono, C
    Barbui, T
    Gisslinger, H
    Barbui, T
    Finazzi, G
    Pusterla, S
    Falanga, A
    Galli, M
    Kutti, J
    Wadenvik, H
    Gastl, G
    Ludescher, C
    Lutz, D
    Girschikofsky, M
    Michlmayr, G
    Rechberger, E
    Niessner, H
    Ivansich, E
    Rain, JD
    Chommienne-Thomas, C
    Hehlmann, R
    Engelich, G
    Kohne, E
    Kramer, A
    Christakis, JI
    Papaioannou, M
    Gerotziafas, G
    O'Donnell, R
    Bennett, M
    Lugassy, G
    Ellis, M
    Eldor, A
    Naparstek, E
    Marilus, R
    Leoni, P
    Rupoli, S
    Scortechini, AR
    Agostini, V
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (02) : 114 - 124
  • [7] Aspirin-insensitive thromboxane biosynthesis in essential thrombocythemia is explained by accelerated renewal of the drug target
    Pascale, Silvia
    Petrucci, Giovanna
    Dragani, Alfredo
    Habib, Aida
    Zaccardi, Francesco
    Pagliaccia, Francesca
    Pocaterra, Davide
    Ragazzoni, Enzo
    Rolandi, Giancarlo
    Rocca, Bianca
    Patrono, Carlo
    [J]. BLOOD, 2012, 119 (15) : 3595 - 3603
  • [8] A randomized double-blind trial of 3 aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia
    Rocca, Bianca
    Tosetto, Alberto
    Betti, Silvia
    Soldati, Denise
    Petrucci, Giovanna
    Rossi, Elena
    Timillero, Andrea
    Cavalca, Viviana
    Porro, Benedetta
    Iurlo, Alessandra
    Cattaneo, Daniele
    Bucelli, Cristina
    Dragani, Alfredo
    Di Ianni, Mauro
    Ranalli, Paola
    Palandri, Francesca
    Vianelli, Nicola
    Beggiato, Eloise
    Lanzarone, Giuseppe
    Ruggeri, Marco
    Carli, Giuseppe
    Elli, Elena Maria
    Carpenedo, Monica
    Randi, Maria Luigia
    Bertozzi, Irene
    Paoli, Chiara
    Specchia, Giorgina
    Ricco, Alessandra
    Vannucchi, Alessandro Maria
    Rodeghiero, Francesco
    Patrono, Carlo
    De Stefano, Valerio
    [J]. BLOOD, 2020, 136 (02) : 171 - 182
  • [9] Polycythemia vera and essential thrombocythemia: 2019 update on diagnosis, risk-stratification and management
    Tefferi, Ayalew
    Barbui, Tiziano
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 (01) : 133 - 143
  • [10] Association of Aspirin Use for Primary Prevention With Cardiovascular Events and Bleeding Events A Systematic Review and Meta-analysis
    Zheng, Sean L.
    Roddick, Alistair J.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 321 (03): : 277 - 287
1